๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Tianjin
Clinical trial register · China

Clinical Trials in Tianjin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China203 Tianjin Medical University Cancer Institute and Hospital170 Tianjin Medical University Second Hospital25 Tianjin Medical University25 Tianjin Medical University General Hospital17
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Tianjin

940 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Post-market Follow Up Study on Paragon CRTยฎ 100 (Paflufocon D)
NCT04187599Myopia
CooperVision International Limited (CVIL)
Not applicable
250
Shanghai, Tianjin, Wenzhou
2019-08-29
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Beijing, Guangzhou, Shanghai, Chengdu, Tianjin, Hangzhou
2019-08-12
Active, closed
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease
Ruijin Hospital
Not applicable
792
Hefei, Fuzhou, Zhengzhou, Changsha, Jinan, Qingdao, Shanghai, Tianjin
2019-08-04
Active, closed
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
NCT03932136Clinical High Risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine
Phase 3
300
Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin
2019-07-14
Active, closed
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
NCT03913949Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
Ascentage Pharma Group Inc.
Phase 1
74
Hefei, Zhengzhou, Wuhan, Tianjin, Hangzhou
2019-06-03
By invitation
Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion
NCT06510634Stroke, Ischemic
Tianjin Huanhu Hospital
Observational
236
Tianjin
2019-06-01
Recruiting
Medical Imaging Screening for Posterior-circulation Ischemic Stroke
NCT06094569Endovascular Thrombectomy
Tianjin Huanhu Hospital
Observational
1,000
Tianjin
2019-06-01
Active, closed
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
NCT03930953Lymphoma, Non-Hodgkin
DrugsValemetostat·Tafasitamab·Golcadomide·Obinutuzumab
Celgene
Phase 1/2
438
Beijing, Guangzhou, Zhengzhou, Wuhan, Shenyang, Shanghai, Tianjin
2019-05-20
Recruiting
A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL
NCT03980002Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
50
Tianjin
2019-05-15
Recruiting
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
NCT03713879Post ERCP Pancreatitis
Chinese University of Hong Kong
Phase 3
1,734
Xi'an, Shanghai, Tianjin, Hangzhou
2019-03-21
By invitation
Outcome of Resection for Colorectal Cancer
NCT03837782Laparoscopy
Tianjin Medical University Cancer Institute and Hospital
Not applicable
1,300
Tianjin
2019-02-15
Recruiting
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693GLP1-R-related Disease, Tumor, Insulinoma, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Active, closed
Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
NCT07298538Unresectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Observational
800
Tianjin
2019-01-01
Recruiting
Translocator Protein PET/CT in Various TSPO-Related Disease
NCT06725719Neuroinflammation, Stroke, Neurodegenerative Diseases
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2018-11-01
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Methotrexate·Vincristine
Takeda
Phase 3
245
Zhengzhou, Suzhou, Changchun, Hangzhou, Tianjin
2018-10-04
Active, closed
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
NCT03529110Breast Cancer
DrugsTrastuzumab emtansine·Trastuzumab deruxtecan
Daiichi Sankyo
Phase 3
524
Beijing, Guangzhou, Harbin, Changchun, Shenyang, Shanghai, Chengdu, Tianjin
2018-08-09
Recruiting
Tau PET/CT in Various Tau-Related Disease Patients
NCT06690983Tauopathies, Neurodegenerative Diseases, Neurodegeneration
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2018-08-01
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
NCT03425643Non-small Cell Lung Cancer
DrugsGemcitabine·Pemetrexed·Cisplatin·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
797
Tianjin, Beijing, Guangzhou, Changsha, Shanghai, Xiโ€™an, Hangzhou, Ningbo
2018-04-24
Active, closed
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
NCT03105102Crohn's Disease
DrugRisankizumab
AbbVie
Phase 3
1,336
Guangzhou, Shijiazhuang, Wuhan, Changsha, Nanchang, Shanghai, Chengdu, Tianjin
2018-04-09
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Beijing, Changchun, Shanghai, Taiwan, Tianjin
2018-01-07
Not yet open
Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer
NCT03367884Hypopharyngeal Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Not applicable
120
Tianjin
2018-01-01
Active, closed
Assessment of IOP After Corneal Refractive Surgery Based on AI
NCT07544615Myopia, Myopia; Astigmatism, Refractive Surgery, Intraocular Pressure Changes
Tianjin Eye Hospital
Observational
10,030
Tianjin
2018-01-01
Active, closed
Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes
NCT06954571Renal Tumors
Tianjin Medical University Second Hospital
Observational
190
Tianjin
2018-01-01
Recruiting
Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
NCT06200753Endovascular Thrombectomy, Large Vessel Occlusion, Acute Ischemic Stroke
Tianjin Huanhu Hospital
Observational
1,000
Tianjin
2018-01-01
Not yet open
Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
NCT03358602Supraglottic Cancer
Tianjin Medical University Cancer Institute and Hospital
Not applicable
158
Tianjin
2017-12-20
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsAG-120·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Zhengzhou, Chengdu, Beijing, Guangzhou, Hangzhou, Tianjin
2017-06-26
Active, closed
Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
NCT03021330AML
Institute of Hematology & Blood Diseases Hospital, China
Phase 3
1,100
Tianjin
2017-02-08
Active, closed
Efficacy and Safety of Chidamide in CBF Leukemia
NCT03031262AML
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
250
Tianjin
2017-02-08
By invitation
Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
NCT03031249AML
DrugsATRA·All-trans retinoic acid·Arsenic Trioxide·Cytarabine
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
80
Tianjin
2017-02-08
Recruiting
CCTA Improves Clinical Management of Stable Chest Pain
NCT04691037Coronary Computed Tomography Angiography, Stable Chest Pain, Optimal Medical Therapy, Invasive Coronary Angiography
Tianjin Chest Hospital
Observational
50,000
Beijing, Langfang, Tianjin
2016-01-01
Active, closed
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
NCT02637687Solid Tumors Harboring NTRK Fusion
DrugLarotrectinib
Bayer
Phase 1/2
154
Beijing, Guangzhou, Tianjin
2015-12-16
Recruiting
China Registry for Genetic / Metabolic Liver Diseases
NCT03131427Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital
Observational
20,000
Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Shanghai, Chengdu, Tianjin, รœrรผmqi
2015-06-13
Recruiting
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
NCT07379463Amino-Acid Transport Disorder, Primary Hyperparathyroidism, Glioma
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2013-08-29
Recruiting
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
NCT06951984Sympathetic Nervous System Diseases, Sympathetic Nervous Structure Injury, Sympathetic Nerve Injury
Tianjin Medical University
Observational
500
Tianjin
2013-03-01
Recruiting
Beta Amyloid PET/CT in Various Aฮฒ-Related Disease
NCT06725706Amyloid, Beta-Amyloid, Neurodegenerative Diseases
Tianjin Medical University
Observational
500
Hefei, Beijing, Qingdao, Tianjin
2012-09-01
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvรฉ-Perthes Disease
NCT02040714Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children
Observational
1,500
Tianjin
2012-08
Recruiting
Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk
NCT00289380Malnutrition, Nutritional Risk
Peking Union Medical College
Observational
2,000
Beijing, Chongqing, Guangzhou, Nanning, Shijiazhuang, Tianjin, Wuhan, Nanjing
2005-01
Recruiting
National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
NCT07019038AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia Mixed Type
Institute of Hematology & Blood Diseases Hospital, China
Observational
9,999
Tianjin
2001-01-01
Recruiting
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766T-LGL Leukemia, NK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Observational
9,999
Tianjin
2000-01-01
Rows per page Showing 901–940 of 940
Previous 8 9 10
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/tianjin?page=10

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 940 of those studies with a site in Tianjin.

How many clinical trials are recruiting in Tianjin?

601 of the 940 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 153 have not yet opened recruitment, 162 are active but closed to new participants, and 24 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.